Skip to content
The Policy VaultThe Policy Vault

Venclexta (venetoclax tablets) — Cigna

Acute Lymphoblastic Leukemia

Initial criteria

  • Patient has relapsed or refractory disease
  • Venclexta will be used in combination with chemotherapy

Approval duration

1 year